We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Finds Novo's Prandin Patent Invalid

Law360 (January 19, 2011, 3:36 PM EST) -- A federal judge Wednesday found the patent for Novo Nordisk A/S diabetes drug Prandin invalid because of obviousness and unenforceable due to inequitable conduct, paving the way for Caraco Pharmaceutical Laboratories Ltd. to market a generic version.

The decision by Judge Avern Cohn of the U.S. District Court for the Eastern District of Michigan comes after a six-year legal battle over whether the patent could be sustained.

The judge ruled that the idea covered by the patent to combine repaglinide with metformin as a combination therapy...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.